Your Health, We Care
The KRAS gene is often mutated in cancer cells, and this mutation causes the cells to grow and spread indefinitely, resulting in the formation of tumors and aggravation of the disease. Adagrasib was developed to target this mutation and provide a new treatment option for lung cancer patients.
